Episode #52 Improving Mental Health in Adolescents with Dr. Scott Shannon

Body of Wonder Podcast In this episode, Dr. Andrew Weil and Dr. Victoria Maizes sit down with Dr. Scott Shannon, a pioneer in integrative psychiatry, to discuss the factors attributed to the growing mental health crisis among adolescents. Dr. Shannon, discusses the role of poor nutrition, reduced physical activity, and the influence of smartphones and social media contributing to rising distress in young people. He examines the potential benefits as well as the challenges of using psychedelics in adolescents. As MDMA and other psychedelics move towards gaining FDA approval, he anticipates there will be pediatric trials. Dr. Weil and Dr. Shannon discuss how, with proper management, psychedelics could offer a less risky alternative to traditional psychiatric medications in adults, as well as children. The discussion also explores non-pharmacological interventions such as transcranial magnetic stimulation and light therapy. Dr. Shannon offers an inside look at modern mental health challenges and the evolving landscape of treatment options, making it a must-listen for anyone interested in the future of adolescent mental health care.

Please note, the show will not advise, diagnose, or treat medical conditions. Always seek the advice of your physician or healthcare provider for questions regarding your health.

Play Episode


Hosts

Andrew Weil, MD and Victoria Maizes, MD

Guest

Scott Shannon , MD

Scott has been a student of consciousness since his thesis on that topic at the University of Arizona in the 1970s. Following medical school, MDMA assisted psychotherapy became part of his practice before this medicine was scheduled in 1985. He completed a psychiatry residency at a Columbia program in New York. Scott also completed a child/adolescent psychiatry fellowship at the University of New Mexico. Scott has published four books on holistic and integrative mental health including the first textbook for this field in 2001. He founded Wholeness Center, the largest integrative mental health center in the US, in 2010. Scott is a past president of two national medical organizations. He served as a site Principal Investigator and therapist for the Phase III trial of MDMA assisted psychotherapy for PTSD. Scott has also published numerous articles about cannabidiol in mental health. He is currently involved with 5-MEO-DMT and LSD research. Scott co-founded the Psychedelic Research and Training Institute (PRATI) to train professionals in ketamine-assisted psychotherapy. Scott served as the initial CEO for the Board of Psychedelic Medicine and Therapies in 2021. He lectures all over the world to professional groups interested in a paradigm shifting perspective about transformative care.

See more